Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Blood Test as a Differential Diagnosis and Drug Efficacy Biomarker in Mental Health

NCT06856161 is registered in ClinicalTrials.gov with Fraser Health as lead sponsor.

NCT NCT06856161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06856161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Blood Test as a Differential Diagnosis and Drug Efficacy Biomarker in Mental Health
Lead sponsor
Fraser Health
Phase
Observational
Overall status
Recruiting
Start date
March 25, 2025
Completion date
August 31, 2027
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol consumption, alcohol use disorder, anxiety disorder (panic disorder or gad), depression - major depressive disorder, mania (neurotic), psychosis, schizophenia disorder, substance use disorders